Skip to content

Nasdaq · CIK 0001095981

CNSY PLUS THERAPEUTICS, INC.

Insider trading from SEC Form 4. Last filing 11 d ago.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company

Signals

Open-market buys and sells at PLUS THERAPEUTICS, INC., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The last 26 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026Howard Clowes
director
MOption exercise
Common Stock
+921$0.00$02,90211 d ago
Oct 1, 2026Richard J Hawkins
director
MOption exercise
Common Stock
+921$0.00$02,45011 d ago
Oct 1, 2026An van Es-Johansson
director
MOption exercise
Common Stock
+921$0.00$01,84311 d ago
Oct 1, 2026Ronald Asbury Andrews
director
MOption exercise
Common Stock
+921$0.00$01,84311 d ago
Oct 1, 2026Andrew John Hugh MacIntyre Sims
Chief Financial Officer
MOption exercise
Common Stock
+1,533$0.00$011,47411 d ago
Oct 1, 2026Marc H Hedrick
Chief Executive Officer
MOption exercise
Common Stock
+6,387$0.00$050,87011 d ago
Oct 1, 2026Kyle Guse
director
MOption exercise
Common Stock
+921$0.00$01,84311 d ago
Oct 1, 2026Marc H Hedrick
Chief Executive Officer
MOption exercise
Common Stock
+8,066$0.00$058,93611 d ago
Oct 1, 2026Howard Clowes
director
MOption exercise
Restricted Stock Unitsderivative
-921$0.00$01,84311 d ago
Oct 1, 2026An van Es-Johansson
director
MOption exercise
Restricted Stock Unitsderivative
-921$0.00$01,84311 d ago
Oct 1, 2026Andrew John Hugh MacIntyre Sims
Chief Financial Officer
MOption exercise
Common Stock
+1,165$0.00$012,63911 d ago
Oct 1, 2026Kyle Guse
director
MOption exercise
Restricted Stock Unitsderivative
-921$0.00$01,84311 d ago
Oct 1, 2026Richard J Hawkins
director
MOption exercise
Restricted Stock Unitsderivative
-921$0.00$01,84311 d ago
Oct 1, 2026Ronald Asbury Andrews
director
MOption exercise
Restricted Stock Unitsderivative
-921$0.00$01,84311 d ago
Oct 1, 2026Marc H Hedrick
Chief Executive Officer
MOption exercise
Common Stock
+1,986$0.00$060,92211 d ago
Oct 1, 2026Andrew John Hugh MacIntyre Sims
Chief Financial Officer
MOption exercise
Common Stock
+287$0.00$012,92611 d ago
Oct 1, 2026Andrew John Hugh MacIntyre Sims
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-1,533$0.00$025,53711 d ago
Oct 1, 2026Marc H Hedrick
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-6,387$0.00$0147,21111 d ago
Oct 1, 2026Andrew John Hugh MacIntyre Sims
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-1,165$0.00$024,37211 d ago
Oct 1, 2026Marc H Hedrick
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-8,066$0.00$0139,14511 d ago
Oct 1, 2026Andrew John Hugh MacIntyre Sims
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-287$0.00$024,08511 d ago
Oct 1, 2026Marc H Hedrick
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-1,986$0.00$0137,15911 d ago
Aug 13, 2025Howard Clowes
director
AGrant or award
Stock Option (Right to Buy)derivative
+297,794$0.00$0297,794Aug 15, 2025
Feb 18, 2025Howard Clowes
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,122$0.00$040,122Feb 20, 2025
Feb 18, 2025Marc H Hedrick
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
+400,489$0.00$0400,489Feb 20, 2025
Feb 18, 2025Richard J Hawkins
director
AGrant or award
Stock Option (Right to Buy)derivative
+40,122$0.00$040,122Feb 20, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

CNSY insider trading: PLUS THERAPEUTICS, INC. | InsiderTell